We also verified whether RPS26 silencing would affect FMRP endogenously expressed in FXTAS patient-derived and control fibroblasts, as they differ in CGG repeats content in natural locus of FMR1, which potentially might influence the effect of RPS26 deficiency. Here, RPS26 is linked to fragile X-associated tremor/ataxia syndrome.